Atherosclerosis

• Diagnosis, Imaging, Screening
• General Information
• Risk Factors
• Risk Reduction
• Treatment

Atherosclerosis

General Information

NEWS:

ARTICLES:

Arteriosclerosis of the extremities

NGC - Atherosclerosis.(2004)

JOURNAL ARTICLES:

A daily glass of red wine: does it affect markers of inflammation? (Alcohol Alcohol. 2005)

Adipocytokines: emerging therapeutic targets. (Curr Atheroscler Rep. 2005)

Adipokines: Molecular links between Obesity and Atheroslcerosis. (Am J Physiol Heart Circ Physiol. 2005)

Arterial endothelial dysfunction in baboons fed a high-cholesterol, high-fat diet. (Am J Clin Nutr. 2005)

Arterial intima-media thickening and endothelial dysfunction in obese Chinese children. (Eur J Pediatr. 2005)

Arterial Stiffness in Chronic Inflammatory Diseases. (Hypertension. 2005)

Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. (Neurology. 2005)

Atherosclerosis as Inflammation. (Ann Vasc Surg. 2005)

Atherosclerosis in Patients With Autoimmune Disorders. (Arterioscler Thromb Vasc Biol. 2005)

[Atherosclerosis: which are the tools available for the practionner?] (Rev Med Suisse. 2005)

Atherosclerotic renal artery stenosis: how big is the problem, and what happens if nothing is done? (J Hypertens. 2005)

Atherosclerotic risk factor control in patients with peripheral arterial disease. (J Vasc Surg. 2005)

Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. (Stroke. 2005)

Characterising atherothrombosis in Hong Kong: results of the Hong Kong data from a global atherothrombosis epidemiological survey. (Hong Kong Med J. 2005)

Circulating adiponectin and plasma Fatty Acid profile. (Clin Chem. 2005)

Components of the Metabolic Syndrome and Carotid Atherosclerosis. (Hypertension. 2005)

Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. (Atherosclerosis. 2005)

Coronary and Aortic Calcification in Women With a History of Major Depression (Arch Intern Med. 2005)

Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. (Atherosclerosis. 2005)

Current understanding of the metabolism and biological actions of HDL. (Curr Opin Clin Nutr Metab Care. 2005)

Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence. (Expert Rev Cardiovasc Ther. 2005)

C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. (Am J Pathol. 2005)

C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population. Edinburgh Artery Study (Circulation. 2005)

Development of atherosclerosis in the diabetic BALB/c mice. Prevention with Vitamin E administration. (Atherosclerosis. 2005)

Dietary fiber, inflammation, and cardiovascular disease. (Mol Nutr Food Res. 2005)

Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis. (Eur J Clin Invest. 2005)

Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men. (Atherosclerosis. 2005)

Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. (J Am Coll Cardiol. 2005)

Elevated Serum C-Reactive Protein Levels and Advanced Atherosclerosis in Youth. (Arterioscler Thromb Vasc Biol. 2005)

Epidemiology of male osteoporosis and prostate cancer. (Curr Opin Urol. 2005)

Exercise reduces preexisting atherosclerotic lesions in LDL receptor knock out mice. (Atherosclerosis. 2005)

Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. (J Nutr. 2005)

HDL as a target in the treatment of atherosclerotic cardiovascular disease. (Nat Rev Drug Discov. 2005)

Hyperhomocysteinemia and atherosclerosis. (Sheng Li Xue Bao. 2005)

Inflammation in Atherosclerosis and Other Conditions: A Response to Danger. (Kidney Blood Press Res. 2005)

Inflammatory mediators in atherosclerotic vascular disease. (Basic Res Cardiol. 2005)

Interactions of C-reactive protein with low-density lipoproteins: Implications for an active role of modified C-reactive protein in atherosclerosis. (Int J Biochem Cell Biol. 2005)

Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? (Diabetes Care. 2005)

Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? (Eur J Cardiovasc Prev Rehabil. 2005)

Is the level of C-reactive protein correlated with the extent of carotid atherosclerosis? (Acta Neurol Belg. 2005)

Kidney insufficiency and nutrient-based modulation of inflammation. (Curr Opin Clin Nutr Metab Care. 2005)

Markers of inflammation and their clinical significance. (Atheroscler Suppl. 2005)

Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness. (Arterioscler Thromb Vasc Biol. 2005)

"New" cardiovascular risk factors in patients with chronic kidney disease: Role of folic acid treatment. (Kidney Int Suppl. 2005)

Prognostic Impact of Fibrinogen in Carotid Atherosclerosis (Stroke. 2005)

Pulse pressure and coronary atherosclerosis progression in postmenopausal women. (Hypertension. 2005)

Radiographic measures of chronic periodontitis and carotid artery plaque. (Stroke. 2005)

Relationship Between C-Reactive Protein and Subclinical Atherosclerosis. The Dallas Heart Study (Circulation 2005)

The Association of C-Reactive Protein Levels With Carotid Intima-Media Complex Thickness and Plaque Formation in the General Population. (Stroke. 2005)

The association of smoking and subclinical atherosclerosis in Type 2 diabetes: modification by duration of diabetes. (Diabet Med. 2005)

The association of subclinical coronary atherosclerosis with abdominal and total obesity in asymptomatic men. (Prev Cardiol. 2005)

The key role of apolipoprotein E in atherosclerosis. (J Mol Med. 2005)

The role of nitric oxide in cardiovascular diseases. (Mol Aspects Med. 2005)

Thrombophilic risk factors in patients with severe carotid atherosclerosis. (J Thromb Haemost. 2005)

When does atherosclerosis become irreversible? Chronological change from an early to an advanced atherosclerotic lesion observed by angioscopy. (Angiology. 2005)

INTERNET SITES:

NIH - Medical Encyclopedia Angioplasty

NIH - Medical Encyclopedia Atherosclerosis

NIH - Medical Encyclopedia Atherosclerosis of internal carotid artery

NIH - Medical Encyclopedia Carotid artery surgery

NIH - Medical Encyclopedia Enlarged view of atherosclerosis

NIH - Medical Encyclopedia Stroke secondary to atherosclerosis

NIH - NCBI Genes and Disease Atherosclerosis

NIH - NHLBI What is Atherosclerosis?

Go to the top